GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 47 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $89,000 | -93.5% | 14,029 | -95.1% | 0.01% | -82.7% |
Q1 2018 | $1,360,000 | +1273.7% | 286,800 | +225.9% | 0.08% | +1925.0% |
Q3 2016 | $99,000 | -89.8% | 87,999 | -86.7% | 0.00% | -92.2% |
Q2 2016 | $974,000 | -36.5% | 662,467 | -38.2% | 0.05% | -33.8% |
Q1 2016 | $1,534,000 | -13.9% | 1,072,765 | -1.3% | 0.08% | -21.4% |
Q4 2015 | $1,782,000 | +3140.0% | 1,086,615 | +6759.1% | 0.10% | +4800.0% |
Q4 2014 | $55,000 | – | 15,842 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Benchmark Capital Advisors | 221,700 | $1,051,000 | 0.83% |
EAM Global Investors LLC | 227,063 | $1,076,000 | 0.56% |
EAM Investors, LLC | 319,187 | $1,513,000 | 0.25% |
COURAGE CAPITAL MANAGEMENT LLC | 30,000 | $142,000 | 0.11% |
Cutter & CO Brokerage, Inc. | 53,600 | $254,000 | 0.10% |
SABBY MANAGEMENT, LLC | 286,800 | $1,360,000 | 0.08% |
D.A. DAVIDSON & CO. | 731,300 | $3,466,000 | 0.07% |
Tibra Equities Europe Ltd | 63,414 | $301,000 | 0.05% |
Advisor Group, Inc. | 556,377 | $2,637,000 | 0.04% |
Laurel Wealth Advisors, Inc. | 21,400 | $101,000 | 0.03% |